Polygot should be taken at the beginning of an attack. For the first dose a dose of 2 tablets is recommended. If Polygot does not improve 30 minutes after taking it, you should take 1 tablet more. The drug can be repeated further at 30 min intervals, not exceeding the maximum daily dose. In subsequent attacks, the initial dose can be increased to 3 tablets, depending on the total dose taken during the previous attacks. The maximum daily dose is 6 mg ergotamine tartrate (6 tablets). The maximum weekly dose is 10 mg ergotamine tartrate (10 tablets). The drug, stops migraine attacks and headaches of vascular genesis. Ergotamine normalizes the tone of dilated extracranial arteries. Caffeine accelerates and increases absorption of ergotamine in the intestine. Not used for prevention of migraine attacks.
The basis of migraine attack prevention is the maximum elimination of migraine triggers, provoking factors. A great role in this is played by the normalization of daily regime, correct alternation of work and rest cycles, avoidance of nervous overstrain and stress loads. Not out of place would be a diet that excludes or reduces the consumption of products that provoke the production of serotonin – smoked meats, cheeses, chocolate, alcohol. Anticonvulsants and antidepressants may also be prescribed as a preventive measure.
Migraine is a serious illness which is very detrimental to life. Since modern medicine cannot completely conquer this disease, it is possible to learn to live with migraine and even enjoy life. Migraine requires serious treatment, but medications can only stop an attack. Migraine medications are used to eliminate the symptoms of the disease – the elimination of severe pain. For migraine with aura, medication can be taken in advance to avoid an attack or to alleviate it.
As with other types of headaches, the diagnosis of migraine is based more on the complaints of patients and does not require additional examination. The basis of diagnosis is a careful questioning of the patient and checking the complaints against the symptoms listed in the International Classification of Headaches.
Sometimes it is possible to identify objective symptoms, which may be reddening of the fingertips, as from a strong cold (Raynaud’s syndrome), moist palms, hyperexcitability of the facial muscles (Chvostek’s symptom), but in most cases the diagnosis of migraine can be made only on the basis of the patient’s complaints. Because of this, the WHO estimates that only 40% of patients receive a correct diagnosis. At the same time, the harm of migraine is globally underestimated, and attitudes toward the disease are sarcastically dismissive. Meanwhile, according to 2013 data, migraine ranks sixth in the world in the number of years lived with disability.
Who is at risk? According to the WHO, the ailment affects people during puberty and peaks by the age of 35-45. It is noteworthy that women are much more susceptible to migraine. The number of applications to the doctor for this disease from women is recorded twice as often. It has also been established that migraine is genetic, so heredity plays an important role in the probability of occurrence of the disease.